Search by Drug Name or NDC
NDC 31722-0545-30 lithium carbonate 300 mg/1 Details
lithium carbonate 300 mg/1
lithium carbonate is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Camber Pharmaceuticals, Inc.. The primary component is LITHIUM CARBONATE.
MedlinePlus Drug Summary
Lithium is used to treat and prevent episodes of mania (frenzied, abnormally excited mood) in people with bipolar disorder (manic-depressive disorder; a disease that causes episodes of depression, episodes of mania, and other abnormal moods). Lithium is in a class of medications called antimanic agents. It works by decreasing abnormal activity in the brain.
Related Packages: 31722-0545-30Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Lithium
Product Information
| NDC | 31722-0545 |
|---|---|
| Product ID | 31722-545_f0c7a72e-0f38-6613-e053-2a95a90a612c |
| Associated GPIs | 59500010100105 |
| GCN Sequence Number | 004001 |
| GCN Sequence Number Description | lithium carbonate CAPSULE 300 MG ORAL |
| HIC3 | H2M |
| HIC3 Description | BIPOLAR DISORDER DRUGS |
| GCN | 15710 |
| HICL Sequence Number | 001669 |
| HICL Sequence Number Description | LITHIUM CARBONATE |
| Brand/Generic | Generic |
| Proprietary Name | lithium carbonate |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | lithium carbonate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CAPSULE |
| Route | ORAL |
| Active Ingredient Strength | 300 |
| Active Ingredient Units | mg/1 |
| Substance Name | LITHIUM CARBONATE |
| Labeler Name | Camber Pharmaceuticals, Inc. |
| Pharmaceutical Class | Mood Stabilizer [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA090702 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 31722-0545-30 (31722054530)
| NDC Package Code | 31722-545-30 |
|---|---|
| Billing NDC | 31722054530 |
| Package | 30 CAPSULE in 1 BOTTLE (31722-545-30) |
| Marketing Start Date | 2009-12-15 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |